Single-cell proteomics: The critical role of nanotechnology
C Arias-Hidalgo, P Juanes-Velasco… - International journal of …, 2022 - mdpi.com
In single-cell analysis, biological variability can be attributed to individual cells, their specific
state, and the ability to respond to external stimuli, which are determined by protein …
state, and the ability to respond to external stimuli, which are determined by protein …
Advancements in oncoproteomics technologies: Treading toward translation into clinical practice
Proteomics continues to forge significant strides in the discovery of essential biological
processes, uncovering valuable information on the identity, global protein abundance …
processes, uncovering valuable information on the identity, global protein abundance …
Recent Applications of Quantitative Mass Spectrometry in Biopharmaceutical Process Development and Manufacturing
X Li - Journal of Pharmaceutical and Biomedical Analysis, 2023 - Elsevier
Biopharmaceutical products have seen rapid growth over the past few decades and
continue to dominate the global pharmaceutical market. Aligning with the quality by design …
continue to dominate the global pharmaceutical market. Aligning with the quality by design …
Recent advances in microfluidics for single-cell functional proteomics
Single-cell proteomics (SCP) reveals phenotypic heterogeneity by profiling individual cells,
their biological states and functional outcomes upon signaling activation that can hardly be …
their biological states and functional outcomes upon signaling activation that can hardly be …
Research Progress in Isotope Labeling/Tags-Based Protein Quantification and Metrology Technologies
F Wu, C Zhang, R Chen, Z Chu, B Han… - Journal of Proteome …, 2024 - ACS Publications
Advanced liquid chromatogram-mass spectrometry (LC-MS) and automated large-scale
data processing have made MS-based quantitative analysis increasingly useful for research …
data processing have made MS-based quantitative analysis increasingly useful for research …
Deep phosphotyrosine characterisation of primary murine T cells using Broad Spectrum Optimisation of Selective Triggering
A Callahan, XY Chua, AA Griffith, T Hildebrandt… - …, 2024 - Wiley Online Library
Sequencing the tyrosine phosphoproteome using MS‐based proteomics is challenging due
to the low abundance of tyrosine phosphorylation in cells, a challenge compounded in …
to the low abundance of tyrosine phosphorylation in cells, a challenge compounded in …
[HTML][HTML] Phosphoprotein dynamics of interacting T cells and tumor cells by HySic
S Ibáñez-Molero, JTM Pruijs, A Atmopawiro, F Wang… - Cell Reports, 2024 - cell.com
Functional interactions between cytotoxic T cells and tumor cells are central to anti-cancer
immunity. However, our understanding of the proteins involved is limited. Here, we present …
immunity. However, our understanding of the proteins involved is limited. Here, we present …
A sensitive and controlled data-independent acquisition method for proteomic analysis of cell therapies
C Lombard-Banek, KI Pohl, EJ Kwee… - Journal of Proteome …, 2022 - ACS Publications
Mass spectrometry (MS)-based proteomic measurements are uniquely poised to impact the
development of cell and gene therapies. With the adoption of rigorous instrumental …
development of cell and gene therapies. With the adoption of rigorous instrumental …
Advancements in Global Phosphoproteomics Profiling: Overcoming Challenges in Sensitivity and Quantification
G Muneer, CS Chen, YJ Chen - Proteomics, 2024 - Wiley Online Library
Protein phosphorylation introduces post‐genomic diversity to proteins, which plays a crucial
role in various cellular activities. Elucidation of system‐wide signaling cascades requires …
role in various cellular activities. Elucidation of system‐wide signaling cascades requires …
CSF1R-CAR T cells induce CSF1R signalling and promote cancer cell growth
A Callahan, X Zhang, A Wang, A Mojumdar, L Zeng… - bioRxiv, 2024 - biorxiv.org
Chimeric antigen receptor (CAR) T cells have transformed the landscape of cancer therapy
and demonstrate unprecedented success in treating relapsed/refractory blood cancers. The …
and demonstrate unprecedented success in treating relapsed/refractory blood cancers. The …